Status:

COMPLETED

Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

Passage Bio, Inc.

Conditions:

GM1 Gangliosidosis

Eligibility:

All Genders

Brief Summary

Owing to the rarity, severity, speed of progression and fatal prognosis of infantile and juvenile GM1, there is a limited understanding of overall disease progression and meaningful outcome measures. ...

Eligibility Criteria

Inclusion

  • Documentation/ Confirmation of reduced beta-galactosidase enzyme activity in leukocytes
  • Confirmed diagnosis of infantile or juvenile GM1 gangliosidosis with documentation of GLB1 mutations
  • Parent/Caregiver capable of providing informed consent (if cognitively able, child to provide assent as well)
  • Infantile (Type 1) GM1 subjects: Documented symptom onset by 6 months of age with significant hypotonia on exam or history elicited from parent(s)/ caregiver(s)
  • Juvenile (Type 2) GM1 subjects: Documented symptom onset after 6 months of age OR documented symptom onset prior to 6 months of age without significant hypotonia on exam or elicited from parent(s)/ caregiver(s)

Exclusion

  • Enrollment in any other clinical study with an investigational product/ therapy (patients receiving miglustat off-label will be eligible)
  • Any clinically significant neurocognitive deficit not attributable to GM1 gangliosidosis or a secondary cause that may, in the opinion of the investigator, confound interpretation of study results
  • Any condition that, in the opinion of the investigator, would put the subject at undue risk or make it unsafe for the subject to participate

Key Trial Info

Start Date :

June 12 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2024

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT04041102

Start Date

June 12 2020

End Date

May 1 2024

Last Update

October 24 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

UCSF Benioff Children's Hospital Oakland

Oakland, California, United States, 94610

2

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

3

Hospital de Clínicas de Porto Alegre

Porto Alegre, Brazil

4

Montreal Children's Hospital Research Institute - McGill University

Montreal, Quebec, Canada